USFDA completes inspections at Suven Pharma facilities with no form 483
Hyderabad: Suven Pharma has announced that the US Food & Drug Administration (US FDA) has completed the inspections at the Company’s Pashamylaram facilities. The inspection was conducted from February 12, 2024, to February 23, 2024. “This is to inform you that our Active Pharmaceutical Ingredients (API) and Formulations facilities (Unit-3 and Unit-5, respectively) in Pashamylaram, Hyderabad, India, […]